Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Rinehart
Lucille P. Markey Cancer Center at University of Kentucky
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Commonwealth Cancer Center
Danville, Kentucky, United States
- Markey Cancer Center
Lexington, Kentucky, United States
- Brown Cancer Center
Louisville, Kentucky, United States
- St. Claire Regional Medical Center
Morehead, Kentucky, United States
- Montgomery Cancer Center
Mount Sterling, Kentucky, United States
- Owensboro Medical Healthcare System
Owensboro, Kentucky, United States
- West Kentucky Hematology & Oncology Group, Psc
Paducah, Kentucky, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2005
- Primary completion
- 31 Jul 2009
- Completion
- 31 Jul 2009
- Last update posted
- 7 Mar 2014
- Registered enrollment
- 60
- Registry id
- NCT00247416
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.